An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers.
Shin SH, Park YH, Park SS, Ju EJ, Park J, Ko EJ, Bae DJ, Kim SY, Chung CW, Song HY, Jang SJ, Jeong SY, Song SY, Choi EK.
Shin SH, et al. Among authors: song sy, song hy.
Adv Sci (Weinh). 2021 Dec;8(23):e2102414. doi: 10.1002/advs.202102414. Epub 2021 Oct 18.
Adv Sci (Weinh). 2021.
PMID: 34664433
Free PMC article.
Clinical Trial.